Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Ola Attman

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
International Journal of Bipolar Disorders|February 14, 2025
Prospects for lithium treated patients with severe renal impairmentHarald Aiff, Per-Ola Attman, Mihaela Golic, et al.
International Journal of Bipolar Disorders|December 9, 2023
Lifetime risk of severe kidney disease in lithium-treated patients: a retrospective studyMihaela Golic, Harald Aiff, Per-Ola Attman, et al.
Kidney International|January 12, 2002
Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiencyDiana M Lee, Carolyn Knight-Gibson, Ola Samuelsson, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 7, 2002
Alterations in lipoprotein composition in peritoneal dialysis patientsJames B Moberly, Per-Ola Attman, Ola Samuelsson, et al.
Clinical Pharmacokinetics|July 9, 2003
Influence of severe renal impairment on the pharmacokinetics and pharmacodynamics of oral ximelagatran and subcutaneous melagatranUlf G Eriksson, Susanne Johansson, Per-Ola Attman, et al.
Kidney & Blood Pressure Research|May 27, 2011
Lipoprotein abnormalities in patients with atherosclerotic renovascular diseaseElzbieta Nowakowska Fortuna, Hans Herlitz, Aso Saeed, et al.
Plos One|August 11, 2011
Oxidative stress and inflammation in renal patients and healthy subjectsDiana M Lee, Kenneth W Jackson, Nicholas Knowlton, et al.
BMC Nephrology|July 21, 2016
A practical approach to low protein diets in Sweden- 45 years of clinical useSintra Eyre, Gerd Faxén-Irving, Per-Ola Attman, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
International Journal of Bipolar Disorders|February 14, 2025
Prospects for lithium treated patients with severe renal impairmentHarald Aiff, Per-Ola Attman, Mihaela Golic, et al.
International Journal of Bipolar Disorders|December 9, 2023
Lifetime risk of severe kidney disease in lithium-treated patients: a retrospective studyMihaela Golic, Harald Aiff, Per-Ola Attman, et al.
Kidney International|January 12, 2002
Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiencyDiana M Lee, Carolyn Knight-Gibson, Ola Samuelsson, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 7, 2002
Alterations in lipoprotein composition in peritoneal dialysis patientsJames B Moberly, Per-Ola Attman, Ola Samuelsson, et al.
Clinical Pharmacokinetics|July 9, 2003
Influence of severe renal impairment on the pharmacokinetics and pharmacodynamics of oral ximelagatran and subcutaneous melagatranUlf G Eriksson, Susanne Johansson, Per-Ola Attman, et al.
Kidney & Blood Pressure Research|May 27, 2011
Lipoprotein abnormalities in patients with atherosclerotic renovascular diseaseElzbieta Nowakowska Fortuna, Hans Herlitz, Aso Saeed, et al.
Plos One|August 11, 2011
Oxidative stress and inflammation in renal patients and healthy subjectsDiana M Lee, Kenneth W Jackson, Nicholas Knowlton, et al.
BMC Nephrology|July 21, 2016
A practical approach to low protein diets in Sweden- 45 years of clinical useSintra Eyre, Gerd Faxén-Irving, Per-Ola Attman, et al.
Pageof 3